Phibro Animal Health Corporation Announces Chief Financial Officer Changes
Phibro Animal Health Corporation (Nasdaq: PAHC) (the “Company” or “Phibro”) today announced that Glenn C. David has joined Phibro and will assume the role of Chief Financial Officer effective February 9, 2024.
- Phibro Animal Health Corporation (Nasdaq: PAHC) (the “Company” or “Phibro”) today announced that Glenn C. David has joined Phibro and will assume the role of Chief Financial Officer effective February 9, 2024.
- Mr. Richard Johnson, who is currently serving as Phibro’s interim Chief Financial Officer since September 29, 2023, will continue with Phibro for a period of time in an advisory capacity to ensure a smooth transition with his successor.
- Glenn brings a wealth of knowledge and experience not only in financial matters but in the animal health industry which will be beneficial for Phibro as we continue to grow our business and bring value to our shareholders.
- He brings the skills and experience needed to play a key role in Phibro’s future success,” said Jack Bendheim, Phibro’s Chairman, President, and Chief Executive Officer.